Trial intelligence / Profile preview

Gemcabene effect on Atorvastatin PK

NCT02587416Phase 1Completed

Sponsor
NeuroBo Pharmaceuticals
Start
Nov 2002
Primary completion
Dec 2002
Modality
Small Molecules
01

Overview

Phase 1, randomised trial of gemcabene in hypercholesterolemia (3 arms), sponsored by NeuroBo Pharmaceuticals. Primary endpoint: Pharmacokinetics at Day 27. Started Nov 2002; status: completed.

02

Drugs

gemcabene
03

Conditions

hypercholesterolemia

Beyond the preview

Go deeper on NCT02587416.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02587416.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call